Skip to main content
SpringerLink
Log in

Critical Care of Guillain-Barré Syndrome

  • Chapter
Critical Care Neurology and Neurosurgery

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 309 Accesses

Abstract

Although the first description of what we now call Guillain-Barré syndrome (GBS) was portrayed by Osler in 1892 (1), the fundamental features of the illness were not fully defined until after the advent of diagnostic lumbar puncture near the turn of the 20th century (2). Because of its potential to cause respiratory failure and severe autonomic nervous system instability, it should be regarded as a potential neurological emergency that may rapidly require specialized intensive care (3,4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Osler W. The Principles and Practice of Medicine. New York: Appleton, 1892: 777–778.

    Google Scholar 

  2. Asbury AK. Guillain-Barre syndrome: Historical aspects. Ann. Neurol. 1990; 27: S2–S6.

    Article  PubMed  Google Scholar 

  3. Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barre syndrome. Crit. Care Med. 1993; 21: 433–446.

    Article  PubMed  CAS  Google Scholar 

  4. Ropper A, Wijdicks E, Truaux B. Guillain-Barre Syndrome. Philadelphia: FA Davis; 1991.

    Google Scholar 

  5. Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology 1985; 35: 1096–1104.

    Article  Google Scholar 

  6. Schonberger LB, Hurwitz ES, Katona P, Holman RC, Bregman DJ. Guillain-Barre syndrome: Its epidemiology and associations with influenza vaccination. Ann. Neurol. 1981; 9: S31–S38.

    Article  Google Scholar 

  7. Larsen JP, Kvale G, Nyland H. Epidemiology of the Guillain-Barre syndrome in the county of Hordaland, Western Norway. Acta. Neurol. Scand. 1985; 71: 43–47.

    Article  PubMed  CAS  Google Scholar 

  8. Alter M. The epidemiology of Guillain-Barre syndrome. Ann. Neurol. 1990; 27: S7–S12.

    Article  PubMed  Google Scholar 

  9. Dowling PC, Menonna JP, Cook SD. Guillain-Barre syndrome in Greater New York-New Jersey. JAMA 1977; 238: 317–318.

    Article  PubMed  CAS  Google Scholar 

  10. Baoxun Z, Yinchang Y, Huifen H, Xiuqin L. Acute polyradiculitis (Guillain-Barre syndrome): An epidemiological study of 156 cases observed in Beijing. Ann. Neurol. 198 1;9:S 146–S 148.

    Google Scholar 

  11. Ropper AH. Campylobacter diarrhea and Guillain-Barre syndrome. Arch. Neurol. 1988; 45: 655–656.

    Article  PubMed  CAS  Google Scholar 

  12. Dowling PC, Cook SD. Role of infection in Guillain-Barre syndrome: Laboratory confirmation of herpesviruses in 41 cases. Ann. Neurol. 1981; 9: S44–S55.

    Article  Google Scholar 

  13. Dowling P, Menonna J, Cook S. Cytomegalovirus complement fixation antibody in Guillain-Barre syndrome. Neurology 1977; 27: 1153–1156.

    Article  PubMed  CAS  Google Scholar 

  14. Hartung HP, Heininger K, Schafer B, Fierz W, Toyka KV. Immune mechanisms in inflammatory polyneuropathy. Ann. NY Acad. Sci. 1988; 540: 122–161.

    Article  PubMed  CAS  Google Scholar 

  15. Cook S, Dowling P. The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barre syndrome. Ann. Neurol. 1981; 9: S163–S170.

    Article  Google Scholar 

  16. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 1969; 48: 173–215.

    Article  CAS  Google Scholar 

  17. Prineas JW. Pathology of the Guillain-Barre syndrome. Ann. Neurol. 1981;9:S6–S 19.

    Google Scholar 

  18. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann. Neurol. 1990; 27: S21–S24.

    Article  PubMed  Google Scholar 

  19. Fisher C. Unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 1956; 255: 57.

    Article  PubMed  CAS  Google Scholar 

  20. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet 1997; 349: 225–230.

    Article  Google Scholar 

  21. Posner JB, Ertel NH, Kossmann RJ, Scheinberg LC. Hyponatremia in acute polyneuropathy. Four cases with the syndrome of inappropriate secretion of antidiuretic hormone. Arch. Neurol. 1967; 17: 530–541.

    Article  PubMed  CAS  Google Scholar 

  22. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain 1986; 109 (Pt 6): 1115–1126.

    Article  PubMed  Google Scholar 

  23. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, et al. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann. Neurol. 1996; 39: 17–28.

    Article  PubMed  CAS  Google Scholar 

  24. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barre syndrome. N. Engl. J. Med. 1995; 333: 1374–1379.

    Article  PubMed  CAS  Google Scholar 

  25. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 1993; 33: 333–342.

    Article  PubMed  CAS  Google Scholar 

  26. Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 1993; 56: 204–206.

    Article  PubMed  CAS  Google Scholar 

  27. Efficiency of plasma exchange in Guillain-Barre syndrome: Role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Ann. Neurol. 1987; 22: 753–761.

    Article  Google Scholar 

  28. Plasma exchange in Guillain-Barre syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. Ann. Neurol. 1992;32:94–97.

    Google Scholar 

  29. Kleyweg RP, van der Meche FG. Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange. J. Neurol. Neurosurg. Psychiatry 1991; 54: 957–960.

    Article  PubMed  CAS  Google Scholar 

  30. Rudnicki S, Vriesendorp F, Koski CL, Mayer RF. Electrophysiologic studies in the Guillain-Barre syndrome: Effects of plasma exchange and antibody rebound. Muscle Nerve 1992; 15: 57–62.

    Article  PubMed  CAS  Google Scholar 

  31. Couriel D, Weinstein R. Complications of therapeutic plasma exchange: a recent assessment. J. Clin. Apheresis 1994; 9: 1–5.

    Article  PubMed  CAS  Google Scholar 

  32. Bouget J, Chevret S, Chastang C, Raphael JC. Plasma exchange morbidity in Guillain-Barre syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit. Care Med. 1993; 21: 651–658.

    Article  PubMed  CAS  Google Scholar 

  33. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N. Engl. J. Med. 1992; 326: 1123–1129.

    Article  PubMed  Google Scholar 

  34. Uldry PA, Bogousslavsky J, Regli F. Guillain-Barre syndrome in a 93-year-old woman: Rapid improvement of neurologic function following intravenous immunoglobulin. Schweiz. Arch. Neurol. Psychiatry 1991; 142: 301–305.

    CAS  Google Scholar 

  35. Zafeiriou DI, Kontopoulos EE, Katzos GS, Gombakis NP, Kanakoudi FG. Single dose immunoglobulin therapy for childhood Guillain-Barre syndrome. Brain Dev. 1997; 19: 323–325.

    Article  PubMed  CAS  Google Scholar 

  36. NIH consensus conference. Intravenous immunoglobulin. Prevention and treatment of disease. JAMA 1990; 264: 3189–3193.

    Article  Google Scholar 

  37. Ratko TA, Burnett DA, Foulke GE, Matuszewski KA, Sacher RA. Recommendations for off-label use of intravenously administered immunoglobulin preparations. University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations. JAMA 1995; 273: 1865–1870.

    Article  PubMed  CAS  Google Scholar 

  38. Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Saf. 1993; 9: 254–262.

    Article  PubMed  CAS  Google Scholar 

  39. Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N. Engl. J. Med. 1986; 314: 560–564.

    Article  PubMed  CAS  Google Scholar 

  40. Cassidy JT, Nordby GL. Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies. J. Allergy Clin. Immunol. 1975; 55: 35–48.

    Article  PubMed  CAS  Google Scholar 

  41. Ellie E, Combe C, Ferrer X. High-dose intravenous immune globulin and acute renal failure. N. Engl. J. Med. 1992; 327: 1032–1033.

    PubMed  CAS  Google Scholar 

  42. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann. Intern. Med. 1994; 121: 259–262.

    PubMed  CAS  Google Scholar 

  43. Voltz R, Rosen FV, Yousry T, Beck J, Hohlfeld R. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin. Neurology 1996; 46: 250–251.

    Article  PubMed  CAS  Google Scholar 

  44. Silbert PL, Knezevic WV, Bridge DT. Cerebral infarction complicating intravenous immunoglobulin therapy for poly-neuritis cranialis. Neurology 1992; 42: 257–258.

    Article  PubMed  CAS  Google Scholar 

  45. Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Guillain-Barre Syndrome Steroid Trial Group. Lancet 1993; 341: 586–590.

    Google Scholar 

  46. Treatment of Guillain-Barre syndrome with high-dose immune globulins combined with methylprednisolone: A pilot study. The Dutch Guillain- Barre Study Group. Ann. Neurol. 1994; 35: 749–752.

    Article  Google Scholar 

  47. Hughes RA, Kadlubowski M, Hufschmidt A. Treatment of acute inflammatory polyneuropathy. Ann. Neurol. 1981; 9: S125–S133.

    Article  Google Scholar 

  48. Andersson T, Siden A. A clinical study of the Guillain-Barre Syndrome. Acta. Neurol. Scand. 1982; 66: 316–327.

    Article  PubMed  CAS  Google Scholar 

  49. Loh L. Neurological and neuromuscular disease. Br. J. Anaesth. 1986; 58: 190–200.

    Article  PubMed  CAS  Google Scholar 

  50. Tobin MJ, Perez W, Guenther SM, Semmes BJ, Mador MJ, Allen SJ, et al. The pattern of breathing during successful and unsuccessful trials of weaning from mechanical ventilation. Am. Rev. Respir. Dis. 1986; 134: 1111–1118.

    PubMed  CAS  Google Scholar 

  51. Grinman S, Whitelaw WA. Pattern of breathing in a case of generalized respiratory muscle weakness. Chest 1983; 84: 770–772.

    Article  PubMed  CAS  Google Scholar 

  52. Ropper AH, Kehne SM. Guillain-Barre syndrome: Management of respiratory failure. Neurology 1985; 35: 1662–1665.

    Article  PubMed  CAS  Google Scholar 

  53. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch. Neurol. 2001; 58: 893–898.

    Article  PubMed  CAS  Google Scholar 

  54. Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome. Am. Rev. Respir. Dis. 1991; 144: 814–818.

    Article  PubMed  CAS  Google Scholar 

  55. Borel CO, Guy J. Ventilatory management in critical neurologic illness. Neurol. Clin. 1995; 13: 627–644.

    PubMed  CAS  Google Scholar 

  56. Fulgham JR, Wijdicks EF. Guillain-Barre syndrome. Crit. Care Clin. 1997; 13: 1–15.

    Article  PubMed  CAS  Google Scholar 

  57. Vincken W, Elleker G, Cosio MG. Detection of upper airway muscle involvement in neuromuscular disorders using the flow-volume loop. Chest 1986; 90: 52–57.

    Article  PubMed  CAS  Google Scholar 

  58. Lanza DC, Parnes SM, Koltai PJ, Fortune JB. Early complications of airway management in head-injured patients. Laryngoscope 1990; 100: 958–961.

    Article  PubMed  CAS  Google Scholar 

  59. Koh WY, Lew TW, Chin NM, Wong MF. Tracheostomy in a neuro-intensive care setting: Indications and timing. Anaesth. Intensive Care 1997; 25: 365–368.

    PubMed  CAS  Google Scholar 

  60. Plummer AL, Gracey DR. Consensus conference on artificial airways in patients receiving mechanical ventilation. Chest 1989; 96: 178–180.

    Article  PubMed  CAS  Google Scholar 

  61. Winer JB, Hughes RA. Identification of patients at risk of arrhythmia in the Guillain-Barre syndrome. Q. J. Med. 1988; 68: 735–739.

    PubMed  CAS  Google Scholar 

  62. Raphael JC, Masson C, Morice V, Brunel D, Gajdos P, Barois A, et al. [The Landry-Guillain-Barre syndrome. Study of prognostic factors in 223 cases]. Rev. Neurol. 1986; 142: 613–624.

    PubMed  CAS  Google Scholar 

  63. Pfeiffer G, Schiller B, Kruse J, Netzer J. Indicators of dysautonomia in severe Guillain-Barre syndrome. J. Neurol. 1999; 246: 1015–1022.

    Article  PubMed  CAS  Google Scholar 

  64. Roubenoff RA, Borel CO, Hanley DF. Hypermetabolism and hypercatabolism in Guillain-Barre syndrome. JPEN 1992; 16: 464–472.

    Article  CAS  Google Scholar 

  65. Ciocon JO, Silverstone FA, Graver LM, Foley CJ. Tube feedings in elderly patients. Indications, benefits, and complications. Arch. Intern. Med. 1988; 148: 429–433.

    Article  PubMed  CAS  Google Scholar 

  66. Cogen R, Weinryb J. Aspiration pneumonia in nursing home patients fed via gastrostomy tubes. Am. J. Gastroenterol. 1989; 84: 1509–1512.

    PubMed  CAS  Google Scholar 

  67. Strong MJ, Rowe A, Rankin RN. Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. J. Neurol. Sci. 1999; 169: 128–132.

    Article  PubMed  CAS  Google Scholar 

  68. Ropper AH, Shahani BT. Pain in Guillain-Barre syndrome. Arch. Neurol. 1984; 41: 511–514.

    Article  PubMed  CAS  Google Scholar 

  69. Connelly M, Shagrin J, Warfield C. Epidural opioids for the management of pain in a patient with the Guillain-Barre syndrome. Anesthesiology 1990; 72: 381–383.

    Article  PubMed  CAS  Google Scholar 

  70. Tripathi M, Kaushik S. Carbamezapine for pain management in Guillain-Barre syndrome patients in the intensive care unit. Crit. Care Med. 2000; 28: 655–658.

    Article  PubMed  CAS  Google Scholar 

  71. Eisendrath SJ, Matthay MA, Dunkel JA, Zimmerman JK, Layzer RB. Guillain-Barre syndrome: psychosocial aspects of management. Psychosomatics 1983; 24: 465–475.

    Article  PubMed  CAS  Google Scholar 

  72. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barre syndrome: Analysis of prognostic factors and the effect of plasmapheresis. Ann. Neurol. 1988; 23: 347–353.

    Article  PubMed  CAS  Google Scholar 

  73. Cornblath DR, Mellits ED, Griffin JW, McKhann GM, Albers JW, Miller RG, et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann. Neurol. 1988; 23: 354–359.

    Article  PubMed  CAS  Google Scholar 

  74. Ropper AH. The Guillain-Barre syndrome. N. Engl. J. Med. 1992; 326: 1130–1136.

    Article  PubMed  CAS  Google Scholar 

  75. Wijdicks EF, Ropper AH. Acute relapsing Guillain-Barre syndrome after long asymptomatic intervals. Arch. Neurol. 1990; 47: 82–84.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michel T. Torbey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Ricardo Carhuapoma
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurosciences Critical Care, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA

    Jose I. Suarez MD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Torbey, M.T., Carhuapoma, J.R. (2004). Critical Care of Guillain-Barré Syndrome. In: Suarez, J.I. (eds) Critical Care Neurology and Neurosurgery. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-660-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-660-7_27

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-350-3

  • Online ISBN: 978-1-59259-660-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation